Xeno Transplants Corporation (XENO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Dec 30, 2025
Xeno Transplants Company Description
Xeno Transplants Corporation operates as a bio-technology research and development company.
The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation.
The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species into humans, such as swine.
Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts.
Xeno Transplants Corporation
| Country | United States |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Elliot Lebowitz |
Contact Details
Address: 143 Gardner Road Brookline, Massachusetts 02445 United States | |
| Phone | 617 566 5228 |
Stock Details
| Ticker Symbol | XENO |
| Exchange | OTCMKTS |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| ISIN Number | US98410N1072 |
| SIC Code | 7373 |
Key Executives
| Name | Position |
|---|---|
| Dr. Elliot Lebowitz Ph.D. | Chief Executive Officer, President and Director |
| Wayne Smith | Chief Financial Officer, Secretary, Treasurer and Director |